Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05932745 · ClinicalTrials.gov registry record · NA
Effects of Novel E-cigarette Constituents on Adults TCORS 3.0
A NA study of Nicotine Use Disorder, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT05932745: Recruiting NA study of Nicotine Use Disorder, sponsored by Yale University.
NCT05932745 is a NA study of Nicotine Use Disorder that is actively recruiting participants, run by Yale University. The registered enrollment target is 66 participants, below the 94-participant average among 7 other Nicotine Use Disorder trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05932745, a NA study of Nicotine Use Disorder, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is an examination of the influence of cooling components of WS-3, WS-23, and menthol on the appeal and addiction potential of nicotine-containing e-liquids among adults.
Primary Outcome
The Labeled Hedonic Scale will be used to ask about liking and wanting of the e-cigarette (one item Visual Analog Scale with ratings ranging from "most disliked sensation imaginable" to "most liked sensation imaginable" with higher values indicating greater liking).
Conditions Studied
Interventions
- OTHER E-liquid coolant (No WS-3) for non-menthol (1)
- OTHER E-liquid coolant (No WS-3) for low (0.1%) menthol (1)
- OTHER E-liquid coolant (No WS-3) for high (2.0%) menthol (1)
- OTHER E-liquid coolant (Low [0.1%] WS-3) for non-menthol (2)
- OTHER E-liquid coolant (Low [0.1%] WS-3) for low (0.1%) menthol (2)
Study Locations (1)
Connecticut
- JB Pierce Lab - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2025-06-20 |
| Est. Completion | 2026-05 |
| Phase | NA |
What NCT05932745 shows while recruiting
NCT05932745 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 94-participant average among 7 other Nicotine Use Disorder trials with a reported enrollment target (30% lower).
The record links to 1 condition, with Nicotine Use Disorder appearing as the primary indexed condition, and to 5 interventions - of which E-liquid coolant (No WS-3) for non-menthol (1) is the first listed.
NCT05932745 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT05932745 about?
NCT05932745 is a clinical study titled "Effects of Novel E-cigarette Constituents on Adults TCORS 3.0". This study is an examination of the influence of cooling components of WS-3, WS-23, and menthol on the appeal and addiction potential of nicotine-containing e-liquids among adults.
What is the current status of trial NCT05932745?
This trial is currently recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2025-06-20. Estimated completion is 2026-05.
What conditions does trial NCT05932745 study?
This clinical trial studies the following conditions: Nicotine Use Disorder.
What interventions are being tested in trial NCT05932745?
The interventions under investigation include: E-liquid coolant (No WS-3) for non-menthol (1) (OTHER), E-liquid coolant (No WS-3) for low (0.1%) menthol (1) (OTHER), E-liquid coolant (No WS-3) for high (2.0%) menthol (1) (OTHER), E-liquid coolant (Low [0.1%] WS-3) for non-menthol (2) (OTHER), E-liquid coolant (Low [0.1%] WS-3) for low (0.1%) menthol (2) (OTHER).
Who is sponsoring clinical trial NCT05932745?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05932745 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Identify the Optimal TMS Pulse Protocol to Modulate Reward Activity
RECRUITING · NA
-
Identify the Optimal TMS Target to Modulate Reward Activity
RECRUITING · NA
-
Temporal Interference Methods for Addiction Treatment
RECRUITING · NA
-
Families With Substance Use and Psychosis: A Pilot Study
COMPLETED · NA
-
Acute Effects of TCIG vs ECIG in PLWH
COMPLETED · NA
-
Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI